Bicocca Open Archive

Logo unimib boa
BIONDI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 64.607
AS - Asia 37.780
EU - Europa 27.620
SA - Sud America 5.480
AF - Africa 868
Continente sconosciuto - Info sul continente non disponibili 61
OC - Oceania 59
Totale 136.475
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 63.063
SG - Singapore 13.353
CN - Cina 7.514
IT - Italia 6.197
VN - Vietnam 5.787
HK - Hong Kong 5.479
RU - Federazione Russa 4.343
BR - Brasile 4.146
DE - Germania 3.318
SE - Svezia 2.994
IE - Irlanda 2.745
UA - Ucraina 1.796
GB - Regno Unito 1.541
FR - Francia 1.388
IN - India 1.085
CA - Canada 1.003
FI - Finlandia 870
BD - Bangladesh 596
ID - Indonesia 569
KR - Corea 541
TR - Turchia 541
AR - Argentina 468
AT - Austria 445
NL - Olanda 414
IQ - Iraq 378
MX - Messico 321
ES - Italia 308
JP - Giappone 300
ZA - Sudafrica 290
PK - Pakistan 282
PL - Polonia 264
SA - Arabia Saudita 224
DK - Danimarca 204
PH - Filippine 202
EC - Ecuador 195
CO - Colombia 182
BE - Belgio 164
VE - Venezuela 154
CH - Svizzera 134
UZ - Uzbekistan 117
CL - Cile 96
EG - Egitto 86
MA - Marocco 83
JO - Giordania 78
AE - Emirati Arabi Uniti 76
PY - Paraguay 76
KE - Kenya 75
IR - Iran 68
MY - Malesia 68
LT - Lituania 67
PE - Perù 65
TN - Tunisia 65
CZ - Repubblica Ceca 64
ET - Etiopia 60
RO - Romania 56
KZ - Kazakistan 52
UY - Uruguay 52
IL - Israele 49
AU - Australia 47
AZ - Azerbaigian 47
GR - Grecia 47
NP - Nepal 45
BG - Bulgaria 44
JM - Giamaica 44
DZ - Algeria 42
TH - Thailandia 42
OM - Oman 39
EU - Europa 38
TW - Taiwan 38
AL - Albania 35
LB - Libano 33
BO - Bolivia 32
DO - Repubblica Dominicana 30
PS - Palestinian Territory 30
CR - Costa Rica 29
PT - Portogallo 29
PA - Panama 28
SN - Senegal 26
NG - Nigeria 25
KG - Kirghizistan 24
NO - Norvegia 24
AO - Angola 20
LV - Lettonia 20
NI - Nicaragua 18
RS - Serbia 18
BH - Bahrain 16
GT - Guatemala 16
SY - Repubblica araba siriana 16
HN - Honduras 15
HR - Croazia 15
AM - Armenia 13
HU - Ungheria 13
TT - Trinidad e Tobago 13
BY - Bielorussia 12
LY - Libia 12
CI - Costa d'Avorio 11
NZ - Nuova Zelanda 11
MN - Mongolia 10
MU - Mauritius 10
SC - Seychelles 10
Totale 136.238
Salva come PNG Salva come JPEG
Città #
Ann Arbor 8.965
Singapore 7.664
Ashburn 5.852
Hong Kong 5.344
Woodbridge 4.520
Fairfield 4.226
Houston 3.577
San Jose 3.374
Chandler 2.783
Dublin 2.644
Wilmington 2.440
Frankfurt am Main 2.092
Jacksonville 1.849
Seattle 1.739
Ho Chi Minh City 1.735
Milan 1.638
New York 1.611
Cambridge 1.460
Hanoi 1.395
Santa Clara 1.282
Dearborn 1.266
Beijing 1.192
Los Angeles 1.161
Chicago 1.127
Princeton 1.003
Hefei 947
Dallas 883
The Dalles 847
Lauterbourg 547
Nanjing 529
Seoul 491
Lawrence 474
Altamura 459
Moscow 459
Shanghai 450
São Paulo 401
Buffalo 399
Jakarta 395
Helsinki 353
Council Bluffs 333
Vienna 329
Lachine 309
San Diego 286
Munich 276
London 252
Orem 234
Rome 231
Tokyo 219
Guangzhou 215
Toronto 211
Dong Ket 200
Warsaw 200
Nuremberg 191
Boardman 190
Haiphong 173
Montreal 173
Denver 170
Andover 169
Da Nang 168
Lissone 159
Baghdad 155
Nanchang 154
Chennai 153
Rio de Janeiro 152
Brussels 150
Brooklyn 149
Changsha 147
Johannesburg 139
Shenyang 133
Stockholm 131
Hebei 128
Tianjin 128
Atlanta 127
Monza 117
Salt Lake City 114
Phoenix 112
Poplar 109
Tashkent 108
Jinan 104
Turku 104
Dhaka 100
Biên Hòa 99
Ottawa 97
Mumbai 95
Manchester 94
Zurich 93
Bologna 92
Amsterdam 91
Brasília 91
Hangzhou 91
Lappeenranta 91
Mexico City 89
Turin 89
Fremont 88
Hải Dương 87
Boston 86
Jeddah 86
Lahore 86
Istanbul 85
Norwalk 85
Totale 88.690
Salva come PNG Salva come JPEG
Nome #
miRNA-regulated gene expression differs in celiac disease patients according to the age of presentation 553
BEYOND THE TUMOUR: CHILDHOOD CANCER PREDISPOSING SYNDROMES [Guardare oltre il tumore: le cancer-predisposingsyndrome in età pediatrica] 520
Four Additional Doses of PEG-L-Asparaginase during the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study 517
Intraperitoneal adoptive transfer of mesenchymal stem cells enhances recovery from acid aspiration acute lung injury in mice 507
Prenatal Origin of Pediatric Leukemia: Lessons From Hematopoietic Development 505
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 497
Maturation signatures of conventional dendritic cell subtypes in COVID-19 suggest direct viral sensing 496
Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels 490
Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action 473
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients 470
Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche 469
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation 463
Enzymatic replacement therapy for Hunter disease: Up to 9 years experience with 17 patients 457
Hepatic granulomatous lesions caused by systemic bartonella vinsonii subsp. arupensis infection in a child 457
First evidence of a paediatric patient with Cornelia de Lange syndrome with acute lymphoblastic leukaemia 450
NIPBL: a new player in myeloid cells differentiation 441
Acute myeloid leukaemia niche regulates response to L-asparaginase 438
Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies 436
IKZF1 plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric b-cell precursor acute lymphoblastic leukemia 433
Cardiofaciocutaneous syndrome and immunodeficiency: data from an international multicenter cohort 433
Acute Myeloid Leukemia Targeting by Chimeric Antigen Receptor T Cells: Bridging the Gap from Preclinical Modeling to Human Studies 431
Studio preliminare sul profilo emotivo di un campione di bambini guariti da leucemia linfoblastica acuta 431
Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960–1999 and registered in the Italian Off-Therapy Registry 425
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 424
Clinical features and outcome of SIL/TAL1-positive t-cell acute lymphoblastic leukemia in children and adolescents: A 10-year experience of the AIEOP group 420
Hodgkin lymphoma in a patient with mosaic trisomy 18: First clinical observation 418
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 416
Development of advanced therapies in Italy: Management models and sustainability in six Italian cell factories 408
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia 406
Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation 398
A simple RNA target capture NGS strategy for fusion genes assessment in the diagnostics of pediatric B-cell acute lymphoblastic leukemia 398
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 392
Combined CAR-T/HSCT approach in a patient with refractory acute lymphoblastic leukemia and cystic fibrosis 391
Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133+ Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy 390
Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection 388
Mesenchymal stromal cells from Shwachman-Diamond syndrome patients fail to recreate a bone marrow niche in vivo and exhibit impaired angiogenesis 386
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 383
GMP-grade preparation of biomimetic scaffolds with osteo-differentiated autologous mesenchymal stromal cells for the treatment of alveolar bone resorption in periodontal disease 380
Moral distress in nurses in oncology and haematology units 378
Phenotypical and Functional Characterization of Mesenchymal Stem Cells Derived From Patients Affected by Schwachman-Diamond Syndrome 378
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia 378
ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells 376
Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring 375
Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency 370
A new case report of severe mucopolysaccharidosis type VII: Diagnosis, treatment with haematopoietic cell transplantation and prenatal diagnosis in a second pregnancy 11 Medical and Health Sciences 1114 Paediatrics and Reproductive Medicine 367
Healthcare costs and resources utilization in children with difficult-to-control asthma treated with biologic therapies: A population-based cohort study 365
Fludarabine as a cost-effective adjuvant to enhance engraftment of human normal and malignant hematopoiesis in immunodeficient mice 364
A second update on mapping the human genetic architecture of COVID-19 361
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL 361
Activin A contributes to the definition of a pro-oncogenic bone marrow microenvironment in t(12;21) preleukemia 361
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 361
Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection 359
Oral nutritional supplementation in children treated for cancer in low- and middle-income countries is feasible and effective: The experience of the children's hospital manuel de jesus rivera "la mascota" in Nicaragua 359
Hematopoietic Stem Cell (HSC)-Independent Progenitors Are Susceptible to Mll-Af9-Induced Leukemic Transformation 358
Interleukin-17-producing t-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation 353
From Adjustment to Thriving: Exploring Well-Being in Young Adult Survivors of Childhood Cancer and Their Siblings 353
A novel EP300 mutation associated with Rubinstein-Taybi syndrome type 2 presenting as combined immunodeficiency 352
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going? 352
CXCR4-MODIFIED CD33.CAR-CIK WITH ENHANCED BONE MARROW HOMING IN ACUTE MYELOID LEUKEMIA 352
Crescere dopo il tumore: Le emozioni dei bambini guariti da leucemia linfoblastica acuta a confronto con quelle di altre popolazioni 351
Diagnosis and monitoring of PML-RARA-positive acute promyelocytic leukemia by qualitative RT-PCR 349
Globalization of pediatric research: Pharmacological RCTs in Latin America 345
TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia 344
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients 342
Perturbations of the T-cell receptor repertoire in response to SARS-CoV-2 in immunocompetent and immunocompromised individuals 339
Immunotherapy of acute leukemia by chimeric antigen receptormodified lymphocytes using an improved Sleeping Beauty transposon platform 339
Children with cancer in the time of COVID-19: An 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy 337
T cells stimulated by CD40L positive leukemic blasts-pulsed dendritic cells meet optimal functional requirements for adoptive T-cell therapy 335
An immune-based biomarker signature is associated with mortality in COVID-19 patients 335
Mapping the human genetic architecture of COVID-19 334
Stable Expression Of Chimeric Antigen Receptors (CARs) By Sleeping Beauty-Mediated Gene Transfer and Efficient Expansion Of Leukemia-Specific Cytokine-Induced Killer (CIK) Cells 333
Human umbilical cord blood-borne fibroblasts contain marrow niche precursors that form a bone/marrow organoid in vivo 332
Antileukemic efficacy of BET inhibitor in a preclinical mouse model of MLL-AF4 + infant ALL 332
Reduced-Intensity delayed intensification in standard-Risk pediatric acute lymphoblastic leukemia defined by undetectable minimal residual disease: Results of an international randomized trial (AIEOP-BFM ALL 2000) 331
Prevalence of Immunological Defects in a Cohort of 97 Rubinstein–Taybi Syndrome Patients 331
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms 330
Location First: Targeting Acute Myeloid Leukemia Within Its Niche 330
Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells. 327
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 327
Mesenchymal stromal cell-secreted chemerin is a novel immunomodulatory molecule driving the migration of ChemR23-expressing cells 327
Acute myeloid leukemia shapes the bone marrow stromal niche in vivo 326
Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia 325
Mesenchymal stromal cell-derived PTX3 promotes wound healing via fibrin remodeling 323
Neonatal combination therapy improves some of the clinical manifestations in the Mucopolysaccharidosis type I murine model 322
Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse 320
Cytoskeletal Regulatory Gene Expression and Migratory Properties of B Cell Progenitors are Affected by the ETV6-RUNX1 Rearrangement 319
Two siblings presenting with novel ADA2 variants, lymphoproliferation, persistence of large granular lymphocytes, and T-cell perturbations 318
Human aplastic anaemia-derived mesenchymal stromal cells form functional haematopoietic stem cell niche in vivo 317
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting 316
Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition 311
Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation 308
Pharmacodynamic effects in the cerebrospinal fluid of rats after intravenous administration of different asparaginase formulations 307
Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati 306
Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome 305
CD34(+) stem cell recovery after positive selection of "overloaded" immunomagnetic columns 304
AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia 304
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia 303
Autologous Purified Peripheral Blood Stem Cell Transplantation Compare to Chemotherapy in Childhood Acute Lymphoblastic Leukemia after Low-Risk Relapse 303
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection 302
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study 302
Totale 37.714
Salva come PNG Salva come JPEG
Categoria #
all - tutte 441.110
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 441.110
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.755 0 0 0 0 0 0 0 0 0 0 725 1.030
2021/20227.503 529 839 954 528 429 516 350 389 572 540 597 1.260
2022/202311.443 1.435 3.409 836 1.011 707 1.702 194 681 748 95 410 215
2023/20248.951 310 290 438 479 1.139 2.268 1.640 318 756 190 282 841
2024/202522.169 1.151 2.332 1.267 1.023 1.856 899 1.489 801 2.275 3.119 1.990 3.967
2025/202649.802 6.909 3.803 3.936 6.022 6.404 2.916 7.552 2.542 4.100 4.627 991 0
Totale 139.459